期刊文献+

Resection and Cryotherapy Combined with Amniotic Membrane Transplantation for the Treatment of Vernal Keratoconjunctivitis with Giant Papillae

Resection and Cryotherapy Combined with Amniotic Membrane Transplantation for the Treatment of Vernal Keratoconjunctivitis with Giant Papillae
下载PDF
导出
摘要 To evaluate the efficacy and safety of resection and cryotherapy combined with amniotic membrane transplantation (AMT) for the treatment of vernal keratoconjunctivitis (VKC) with giant papillae (GP). Eight patients (16 eyes involved) with VKC, characterized by GP on the upper tarsal conjunctiva, underwent resection and cryotherapy in combination with AMT. The follow-up lasted for 3-22 months. The results showed that corneal shield ulcers and superficial punctuate keratitis healed during the first week after surgery and did not recur. Fourteen eyes (87.5 %) were symptom-free 1 month after surgery, and no GP, ectropion, trichiasis and other complications were noted, but the blood vessels of upper tarsal conjunctiva could not be clearly seen and a little conjunctival scar was observed. Recurrence of GP was observed in 2 eyes (12.5 %), with the area being less and irritation milder as compared with those before the operation. Among the two eyes, one eye was treated by cyclosporine eyedrops with improvement, but the other eye showed no improvement after the treatment, and underwent a second surgery with a cotton patch soaked in fluorouracil applied onto the su-pratarsal area after resection and cryotherapy. Four months after the treatment the patient presented no symptoms and GP did not recur. It is concluded that the resection and cryotherapy combined with AMT is an effective and safe treatment for VKC with GP. To evaluate the efficacy and safety of resection and cryotherapy combined with amniotic membrane transplantation (AMT) for the treatment of vernal keratoconjunctivitis (VKC) with giant papillae (GP). Eight patients (16 eyes involved) with VKC, characterized by GP on the upper tarsal conjunctiva, underwent resection and cryotherapy in combination with AMT. The follow-up lasted for 3-22 months. The results showed that corneal shield ulcers and superficial punctuate keratitis healed during the first week after surgery and did not recur. Fourteen eyes (87.5 %) were symptom-free l month after surgery, and no GE ectropion, trichiasis and other complications were noted, but the blood vessels of upper tarsal conjunctiva could not be clearly seen and a little conjunctival scar was observed. Recurrence of GP was observed in 2 eyes (12.5 %), with the area being less and irritation milder as compared with those before the operation. Among the two eyes, one eye was treated by cyclosporine eyedrops with improvement, but the other eye showed no improvement after the treatment, and underwent a second surgery with a cotton patch soaked in fluorouracil applied onto the supratarsal area after resection and cryotherapy. Four months after the treatment the patient presented no symptoms and GP did not recur. It is concluded that the resection and cryotherapy combined with AMT is an effective and safe treatment for VKC with GP.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2006年第5期618-620,共3页 华中科技大学学报(医学英德文版)
关键词 冷冻疗法 角膜结膜炎 病理 治疗 anmiotic membrane transplantation giant papillae vernal keratoconjunctivitis
  • 相关文献

参考文献1

二级参考文献9

  • 1Bleik JH, FRCS, Tabbara KF. Topical Cyclosporine in vernal keratoconjunctivitis. Ophthalmology, 1991, 98: 1679~ 1684
  • 2Akpek EK, Hasdiripi H, Christer WG, et al. A randomized trial of low dose, topical mitomycin C in the treatment of severe vernal keratoconjunctivitis. Ophthalmology, 2000, 107 (2): 263~269
  • 3Nishiwaki - Dantas MCM, Dantas PE, Pezzutt S, et al. Surgical resection fo giant papillae and autologous conjunctival graft in patients with severe vernal keratoconjunctivitis and giant papillae. Ophthal Plast Reconstr Surg, 2000, 16 (6): 438~442
  • 4BenEzra D, Pe'er J, Brodsky M, et al. Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctives. Am J Ophthalmol,1986, 101 (3): 278~282
  • 5Hikita N, Lopez JS, Chan CC, et al. Use o topical FK506 in a corneal graft rejection model in Lewis rats. Invest Ophthalmol Vis Sci,1997, 38 (5): 901~909
  • 6Kino T, Hatanaka H, Miyata S, et al. FK506, a novel immunosuppressant isolate from a Streptomyces Ⅱ. immunosuppressive effect of FK506 in vitro. J Antibiot, 1987, 9:1256~1265
  • 7Leonardi A, DeFranchis GF, et ald. Effects of cyclosporin A on human conjunctival fibroblasts. Arch Ophthalmol, 2001, 119 (10):1512~1517
  • 8林跃生,陈家祺,刘永民,周世友,谢汉平,王敏华.眼表重建术后局部应用FK-506的初步临床观察[J].眼科新进展,2000,20(4):249-251. 被引量:5
  • 9谢汉平,陈家祺,林跃生,刘永民,叶成添.FK506滴眼液联合角膜移植术治疗复发性蚕蚀性角膜溃疡[J].中华眼科杂志,2002,38(1):13-15. 被引量:25

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部